Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure

Table 3 E2 concentration of each group at each time point

Items	Before transplantation	After transplantation
		1 d	15 d	30 d	45 d	60 d
Negative control group	56.94 ± 4.43	51.42 ± 2.35	53.99 ± 2.73	53.43 ± 3.26	52.04 ± 1.65	55.43 ± 1.57
Model group	55.23 ± 4.35 (P = 0.147)	35.41 ± 2.25	28.32 ± 1.51	24.86 ± 0.90	22.16 ± 1.25	18.99 ± 1.40
hUCMSC group	55.83 ± 3.35 (P = 0.325)	37.84 ± 1.69	38.33 ± 1.79	35.04 ± 2.31	35.12 ± 1.47	34.10 ± 1.42
Positive control group	55.03 ± 3.43 (P = 0.357)	37.34 ± 1.86	37.80 ± 1.83	36.86 ± 2.09	36.86 ± 1.11	37.08 ± 1.47
P value	P > 0. 05

hUCMSC: Human umbilical cord mesenchymal stem cell.